The Beauty Health Company (SKIN) Consumer Conference Presentation Confirms Pathway to Mid 20s EBITDA Margins - Jefferies
Tweet Send to a Friend
Jefferies analyst Stephanie Wissink reiterated a Buy rating and $24.00 price target on The Beauty Health Company (NASDAQ: SKIN) after ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
